Sun Pharmaceutical Industries Limited at the SBM held on 31 July 2025, the board has approved changes in the composition of the Board Committees: Nomination and Remuneration Committee: Mr. Dilip Shanghvi is appointed as a member with immediate effect and Mr. Sudhir Valia ceases to be a member upon his retirement at the conclusion of the 33rd Annual General Meeting. Stakeholders Relationship Committee: Mr. Aalok Shanghvi is appointed as a member with immediate effect and Mr. Kirti Ganorkar is appointed as a member of the Committee to replace Mr. Dilip Shanghvi effective from 1 September 2025. This is subject to the approval of the shareholders for his appointment as a board member.
Mr. Sudhir Valia ceases to be a member upon his retirement at the conclusion of the 33rd Annual General Meeting. Risk Management Committee: Mr. Aalok Shanghvi is appointed as a member with immediate effect and Mr. Sudhir Valia ceases to be a member upon his retirement at the conclusion of the 33rd Annual General Meeting. Corporate Social Responsibility Committee: Ms. Vidhi Shanghvi is appointed as a member with immediate effect and Mr. Sudhir Valia ceases to be a member upon his retirement at the conclusion of the 33rd Annual General Meeting.
